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Background/Aims. Transcriptionally active and inactive topologically associated domains (TADs) 
occupy different areas in the cell nucleus, and chromosomal rearrangements relocating TADs could 
determine ectopic expression of the repositioned genes. In this study, we investigated the HLXB9 gene 
in a myeloid leukaemia cell line, GDM-1, known to harbour a rearrangement involving the 
chromosome 7 with breakpoint distal to HLXB9, highly expressed in these cells. 
Methods. We used fluorescence in situ hybridisation (FISH) to target the regions involved in the 
translocation and to distinguish the translocated chromosome from the non-translocated one in 
interphase nuclei. 
Results. Two-dimensional (2D) analysis of the interphase FISH data indicated that the two HLXB9 
alleles had a different localisation in the cell nuclei, with the translocated allele consistently positioned 
in the nuclear periphery and the normal one in the more internal portion of the nucleus, known as the 
transcriptionally active compartment. 
Conclusion. Our data may indicate that HLXB9 transcripts in GDM-1 cell line do not arise from the 
allele located in the rearranged chromosome 7, suggesting that regulation of gene expression in cancer 
cells harbouring chromosomal translocations might be more complex than previously thought, paving 




For more than two decades, a significant proportion of genome research has focused on the 
understanding of the nuclear architecture, where genes and chromosomal regions are positioned 
according to a precise order that depends mostly on gene density. Seminal work showed that in the 
interphase nuclei, human chromosomes are arranged in the so-called chromosome territories [Croft et 
al., 1999; Cremer and Cremer, 2001], whose organization and gene distribution define nuclear 
compartments endowed with different structural and functional properties [Saccone et al., 2002; 
Federico et al., 2008; Bernà et al., 2012], with the transcriptionally active chromatin preferentially 
located more internally in the nucleus, whereas the transcriptionally inactive one, particularly the 
heterochromatin, occupies the nuclear or the nucleolar periphery [Andrulis et al., 1998; Lukasova et 
al., 2002; Foster and Bridger, 2005; Dekker et al., 2013; Mattout, et al., 2015; Bernardi, 2015]. The 
correct maintenance of the higher order chromatin structure is crucial for cellular health, and its 
alteration is an emerging factor in human cancer, including leukaemia [Bártová et al., 2000; Ballabio 
et al., 2009; Tosi et al., 2015]. 
In the past decade or so, the observations obtained using microscope imaging and analysis of FISH 
data were further supported by the introduction of chromosome conformation capture (3C) technique 
[Dekker et al., 2002] and its variants, such as the high-throughput chromosome conformation capture 
(Hi-C) [Lieberman-Aiden et al., 2009]. These methods allowed a better understanding of the complex 
interplay between different parts of the genome, their positioning within the nuclear space and how 
changes in the relative genomic DNA positioning can influence transcription. 3C based studies 
highlighted the presence, in the cell nucleus, of topologically associated domains (TADs), namely 
genomic DNA sequences identified by their large degree of reciprocal physical interactions and 
endowed with different properties. Transcriptionally active or inactive TADs are located in the more 
internal or in the more peripheral nuclear compartment respectively [Stevens et al., 2017], as 
previously defined by molecular cytogenetic methods. Moreover, TADs located at the periphery of the 
cell nucleus are endowed with relevant properties that favour association to the nuclear lamina (lamina 
associated domains or LADs) [Kind et al., 2015] 
HLXB9, a gene mapping on chromosome 7q36.3, also known as MNX1 (motor neuron and pancreas 
homeobox), belongs to the family of EHG homeobox genes which also includes EN1, EN2, GBX1 and 
GBX2 [Holland, 2001]. Human HLXB9 is a gene of 12,801 bp, composed of 3 exons, and the 
corresponding protein is a transcription factor, HB9, of 401 aminoacids [Harrison et al., 1994; 
Wildenhain et al. 2012]. During development, HB9 controls pancreas and motoneuronal 
differentiation [Arber et al., 1999; Harrison et al., 1999]. The HLXB9 gene is mutated in constitutional 
disorders such as the Currarino syndrome, characterized by anorectal malformations and sacral 
agenesis [Ross et al., 1998]. Physiologically, HLXB9 is transiently over-expressed during the early 
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stages of in vitro neuronal-like differentiation of neuroblastoma cells and this overexpression is 
associated with HLXB9 gene repositioning towards the nuclear interior [Leotta et al., 2014].  
HB9 is selectively present at high levels in bone marrow CD34-positive cells. The differentiation of 
hematopoietic progenitor cells along lineage-specific lines is accompanied by a HLXB9 down-
regulation [Deguchi and Kehrl, 1991]. Interestingly, homeobox genes overexpression is well 
documented in leukaemia [Alharbi et al., 2013]. Indeed ectopic expression of GBX2 has been shown 
in avian leukaemia, whereas HLXB9 overexpression has been detected in acute myeloid leukaemia 
(AML) [Deguchi et al., 1993; Kowenz-Leutz et al., 1997; Beverloo et al., 2001]. In particular, over-
expression of the HLXB9 gene was found in association with its altered positioning in the nucleus of 
leukaemic cells carrying the t(7;12)(q36;p13) rearrangement [Ballabio et al., 2009]. Leukemia derived 
cell lines are a useful tool for the study of genome organisation in relation to gene expression in this 
pathology. In particular, the acute myeloid leukaemia derived cell line GDM-1 [Ben-Bassat et al., 
1982] was already subject of investigations that showed over-expression of the HLXB9 gene [Nagel et 
al., 2005]. This cell line harbours a translocation between chromosomes 6 and 7, precisely 
t(6;7)(q23;q36), with the breakpoint on chromosome 7 distal to HLXB9 and upstream of MYB at 6q23, 
a gene often activated in leukaemia [Nagel et al., 2005; Mostafa Kamel et al., 2014]. The mechanism 
for HLXB9 activation in the GDM-1 cell line is yet to be elucidated and so is the impact of ectopic 
overexpression of HLXB9 in the pathogenesis of leukaemia. In the work here presented, we used dual 
colour interphase fluorescence in situ hybridisation (FISH) to obtain a map of the cell nucleus in 
which both alleles of HLXB9 could be visualised and identified simultaneously. We observed that the 
derivative chromosome containing the translocated HLXB9 allele maintained a peripheral position, 
whereas the non-translocated homolog was repositioned towards the nuclear interior. 
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Materials and methods 
Cell cultures 
Human leukaemia GDM-1 cell line (from “Biological bank and Cell Factory” IST, Genova, Italy - 
code number HTL01008) was grown at 37 °C and 5% CO2, in RPMI 1640 supplemented with foetal 
bovine serum (FBS) to a final concentration of 20%, 1% Penicillin/Streptomycin (P/S) and 1% L-
Glutamine [Ben-Bassat et al., 1982]. 
Human lymphocytes were obtained from whole peripheral blood samples of healthy volunteers who 
signed the informed consent, and cell separation with Ficoll solution. Phytohaemagglutinin (PHA) 
stimulated lymphocytes were obtained by 72 hours culture in RPMI 1640 supplemented with 10% 
foetal bovine serum, 1% Penicillin/Streptomycin, 1% L-Glutamine, 3% PHA at 37 °C, with 5% CO2. 
 
In situ hybridization on chromosomes and nuclei 
To prepare metaphase chromosomes, colcemid (0.05 µg/ml) was added to cell cultures 1 hour before 
harvesting. Then, cells were harvested in hypotonic solution (KCl 0.075 M) and fixed with methanol-
acetic acid (3:1). Interphase nuclei were obtained using a protocol to preserve the 3D chromatin 
structure, as previously described [Leotta et al., 2014]. Briefly, cells were fixed in 4% 
paraformaldehyde in PBS for 10 min, washed in PBS, incubated in 0.5% Triton X-100 in PBS for 15 
min, and then in 20% glycerol in PBS for 30 min. Cells were then frozen in liquid nitrogen and thawed 
at room temperature, washed in PBS, and finally incubated for 5 min in 0.1 N HCl. 
Fluorescence in situ hybridization (FISH) experiments were performed using specific probes (Table 1) 
for loci flanking the breakpoint regions on chromosomes 6 and 7. One of the probes, PAC RP5-
1121A15 (GenBank accession no. AC006357.5), contains the entire HLXB9 gene, the other two 
probes are the PAC RP1-48H15 (kindly provided by Stephen Scherer and Jeff MacDonald Toronto 
Hospital for Sick Children, Canada) and RP11-474A9 (kindly provided by M. Rocchi, University of 
Bari, Italy), mapping at 7q36.3 and 6q24.3 respectively. Each probe DNA was extracted from bacteria 
using a commercial kit (Qiagen, Milan, Italy), digoxigenin or biotin-labelled by nick translation 
(Roche, Mannheim, Germany), and hybridized as previously described [Leotta et al., 2014]. Detection 
was carried out using rhodamine conjugated avidin (for biotin-labelled probes), and anti-digoxigenin 
secondary antibody conjugated with fluorescein (for digoxigenin-labelled probes). 
 
Radial nuclear location analysis 
Radial nuclear location (RNL) of HLXB9 gene was determined using the two dimensional (2D) FISH 
analysis as previously described [Federico et al., 2008]. Briefly, images of hybridised nuclei were 
randomly acquired using an epifluorescence microscopy (Olympus AX70) equipped with a CCD 
camera (COHU 4910 series), and recorded using MacProbe v4.3 software (Applied Imaging, 
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Newcastle, UK). Each hybridized nucleus was analysed using a dedicated software developed at the 
University of Catania [Federico et al., 2008] in order to obtain the RNL for each hybridization signal. 
This was the value defined by the ratio of its position relative to the nuclear radius (0 and 1 indicate 
the centre and the periphery of the nucleus, respectively). The assessment of RNL was then based on 
the statistical analysis of at least 300 hybridization signals from the randomly recorded nuclei on at 
least three different experiments for each probe. RNL was statistically defined as the median value ± 
confidence interval (C.I.) of all the analysed hybridization signals. It was established, analysing a high 
number of probes [Federico et al., 2008; Ballabio et al. 2009; Federico et al., 2017 and other our 
unpublished data], that median values of 0.65 could be considered a landmark between loci located at 
the nuclear periphery and at the nuclear interior. Differences in the RNLs were statistically evaluated 
by two tails T-test. Statistical values and analyses were performed with Microsoft Excel and StatView 
softwares. 
 
Expression analysis and immunodetection 
HLXB9 total RNA was extracted from GDM-1 cells using the TRI Reagent (SIGMA-ALDRICH, St. 
Louis, USA), according to the manufacturer’s instructions, and used in Real Time quantitative PCR 
(RT-Q-PCR) experiments (StepOne, Applied Biosystems) with primers (SIGMA-ALDRICH, St. 
Louis, USA) specifically designed for target and control genes (Table 2) using One-step SYBR Green 
RT-Q-PCR mix (Invitrogen, Carlsbad, CA, USA). RT-Q-PCR experiments, performed according to 
the manufacturer instructions, were repeated at least three times. Data were analysed using the Ct 
value and comparison with the endogenous ACTB gene used as control. Total RNA extracted as above 
from whole blood samples, of healthy subjects, were used as negative control. 
Experiments of indirect immunofluorescence (IIF) were performed as previously described [Maugeri 
et al., 2016]. Briefly, GDM-1 and control cells were fixed with 4% paraformaldehyde for 20 min at 
room temperature, washed with PBS, incubated 15 min in PBS containing 0.5% Triton X-100, and for 
20 min in blocking solution. The cells were then incubated with HB9 antibody (Sigma-Aldrich, 1:100 
dilution) overnight at 37°C. After PBS/tween-20 washes, the cells were incubated for 1 hour with anti-
rabbit secondary antibody conjugated with FITC (Invitrogen, 1:100 dilution) at 37°C, washed in 
PBS/tween-20, dehydrated in alcohol and stained with DAPI. Images were captured using a Confocal 




GDM-1 cells were previously shown to overexpress HLXB9 gene [Nagel et al., 2005]. This was 
confirmed in the present work by RT-Q-PCR and by IIF that showed high levels of HLXB9 transcript 
as well as high amount of HB9 protein (Fig. 1). In addition, GDM-1 cell line validation was obtained 
by identification of the typical chromosomal translocation t(6;7)(q23;q36), present in these cells, by 
karyotype analysis (data not shown) and by FISH results with probes specific for this chromosomal 
translocation (see Fig. 2). 
RNL of the HLXB9 gene has been assessed in the leukaemia derived cell line GDM-1 using dual 
colour FISH with probes that consented discrimination of the two alleles in the nuclei hybridized (Fig. 
2). We used the digoxigenin-labelled PAC RP5-1121A15 (containing HLXB9) in combination with 
biotin-labelled BAC RP11-474A9 close to the breakpoint on chromosome 6 (probe set-A), or with the 
PAC RP1-48H15 telomeric to HLXB9 on chromosome 7 (probe set-B) (Fig. 2). This latter probe, not 
previously described, is telomeric respect to the HLXB9/MNX1 gene and is precisely detailed in Fig. 
2E and in Table. 1. Using these specific probes, it was possible to distinguish the HLXB9 wild-type 
allele (HLXB9 in normal chr7) from the one located on the translocated chromosome, the der(7), 
making it possible to obtain a specific RNL for each of the two alleles by 2D analysis (Fig. 3). 
Median values obtained for HLXB9 allele on the der(7) were 0.663 and 0.652, with the probe set-A 
and the probe set-B respectively. For the HLXB9 allele in the non-translocated chromosome 7 the 
median values were 0.595 and 0.610, with the probe set-A and the probe set-B respectively. The shift, 
in the cell nucleus of the GDM-1 cells, of the HLXB9 allele (present in the not rearranged 
chromosome 7) from a peripheral location (RNL median value higher than 0.65) to a more internal 
one (RNL median value close to 0.60) is statistically highly significant (P<0.001) (Fig. 3). This is also 
schematically visualised in the cartoon presented in Fig. 4. It should be stressed that the RNL of the 
HLXB9 located on the der(7) is similar to RNL of the gene in the nuclei of PHA-induced lymphocytes 
used as controls (Fig. 3) and is different from the one located on the non-rearranged chromosome 7. 
Analysis of the genomic features of the terminal q arm of chromosomes 6 and 7, showed that the 
segment of chromosome 6 translocated onto chromosome 7 contains a large number of LADs. 
Moreover the rearrangement determines a juxtaposition of a GC-poor region of chromosome 6 with a 




Our previous studies showed that ectopic overexpression of the homeobox gene HLXB9 was driven by 
the t(7;12)(q36;p13) rearrangement found in infant acute myeloid leukaemia. This chromosomal 
translocation implied a repositioning of the translocated HLXB9 allele to a more internal area of the 
cell nucleus, where transcription is generally more active [Ballabio et al., 2009]. Using the myeloid 
leukaemia derived cell line GDM-1, also known to overexpress HLXB9 [Nagel et al., 2005], we 
investigated whether nuclear repositioning of HLXB9 was also detectable. GDM-1 karyotype was 
reported to contain a translocation between chromosome 6 and chromosome 7, precisely a 
t(6;7)(q23;q36), with chromosome 7 breakpoint distal to the HLXB9 gene at 7q36.3 [Mostafa Kamel et 
al., 2014; Nagel et al., 2005]. Although both t(7;12) and t(6;7) rearrangements are associated with 
acute myeloid leukaemia and disrupt chromosome 7 in the 7q36 region, the breakpoints are slightly 
different and map precisely proximal, in the t(7;12) leukaemias, and distal, in the t(6;7) observed in 
GDM-1, to the HLXB9 gene. In both cases HLXB9 itself is not disrupted by the translocation, but ends 
up close to a gene with potential to drive transcription, that is ETV6 on chromosome 12 or MYB on 
chromosome 6. However, we could speculate that HLXB9 transcripts in these two leukaemia scenarios 
might have different origin. 
Through radial nuclear localisation, it was deduced that the translocated HLXB9 allele in the t(7;12) 
leukaemia cells was responsible for transcription, because it was repositioned to a more internal area 
of the cell nucleus, where transcription is more likely to occur. Similar RNL studies on GDM-1 
presented here, showed a more interior localisation of the non-translocated HLXB9 allele. The 
rearranged chromosome 7 remains in the same peripheral nuclear area where the HLXB9 gene is 
physiologically located and transcriptionally inactive, in the PHA-stimulated lymphocytes [Federico et 
al., 2008; Ballabio et al., 2009]. Moreover, the chromosome 6 segment (about 36 Mb of genomic 
DNA) translocated to the telomeric end of the chromosome 7, is very GC-poor and contains a large 
number of LADs (see Fig. 5). Thus, the translocation of this chromosomal segment could be 
responsible for the preservation of the peripheral location of HLXB9. 
These findings may suggest that there are different ways to instigate transcription arising from a 
chromosomal translocation. Traditionally, gene overexpression due to juxtaposition of an active one is 
a widely accepted mechanism in cancer biology. However, one could suppose that in GDM-1 gene 
regulation may be somehow driven by the der(7) via activation of the HLXB9 gene located on the non-
translocated chromosome 7. This might imply that the chromosomal rearrangement had a broader 
effect on the genome organisation and not only an ectopic interaction between elements in cis. It is 
also possible that an alteration of the nuclear architecture due to the presence of additional 
chromosomal abnormalities could be inducive to altered expression patterns, including HLXB9 over-
expression. Altogether this study has generated few more questions on the role of HLXB9 in 
leukaemogenesis, opening new avenues for research on the topic. Further epigenetics studies would 
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clarify methylation patterns responsible for gene silencing. Additionally, chromosome conformation 
capture methods would help understanding the physical interactions between distal regulatory 
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TABLE 1. List of probes used in FISH experiments 




 Length, bp 
RP5-1121A15 PAC 7q36.3 156,689,179 156,819,479 130,301 
RP1-48H15 PAC 7q36.3 156,805,535 156,877,583 72,049 
RP11-474A9 BAC 6q24.3 145,609,951 145,804,203 194,253 
(a)
Positional data are from the Human Genome Assembly hg19 (GRCh37, Feb. 2009). 
 
 
TABLE 2. PCR primers used in the present study 
Human Gene PCR segment Size Nucleotide sequence (5’-3’) 
HLXB9 98 bp 
Forward GTTCAAGCTCAACAAGTACC 
Reverse GGTTCTGGAACCAAATCTTC 








Fig. 1. Expression of the HLXB9 gene in GDM-1 cell line. Left: RT-Q-PCR showing the relative 
expression of HLXB9 gene in the GDM-1 cells compared to the internal control ACTB gene. 1 and 2 
show data from two negative controls (total RNA from human peripheral blood). Right: IIF of the 
HB9 protein (green signals), in the GDM-1 (upper part) and negative control (bottom part) cells. 






Fig. 2. Localization of HLXB9 alleles in chromosomes and nuclei of the GDM-1 cell line. Upper 
left: ideograms of the human chromosomes 6 and 7 indicating the position of the probes used in this 
study. Probe no. 1 (RP11-474A9) is telomeric to the breakpoint on chromosome 6 and probes no. 2 
(RP5-1121A15, containing the entire HLXB9/MNX1 gene) and no. 3 (RP1-48H15) flank the 
breakpoint on chromosome 7. A and B: representative metaphase and nucleus hybridized in the GDM-
1 cells with probes no. 1 and no. 2 (probe set-A) detected with rhodamine (red) and fluorescein (green) 
respectively. C and D: representative metaphase and nucleus hybridized with probes no. 2 and no. 3 
(probe set-B) detected with fluorescein (green) and rhodamine (red) respectively. Chromosomes and 
nuclei were stained with DAPI (blue). E: description of the PAC probe RP1-48H15, not previously 
published and not present in public databases. PAC RP1-48H15 was precisely positioned in the hg19 
assembly by localization of the end sequences (described in the additional file-1). RP5-1121A15 
(AC006357.5) and RP1-48H15 show an overlapping region of 13.9 kb. Further data and the format 
used are from UCSC genome browser (http://genome.ucsc.edu/). 
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Fig. 3. Radial nuclear localization of HLXB9 alleles. A: median values (and the relative confidence 
interval, C.I.) of the nuclear location relative to the hybridised probes (see figure 2 for maps of probes 
on chromosomes). On the left side of the graph, 1 and 2 indicate lymphocyte samples from two 
different healthy subjects used as controls, whereas values relative to GDM-1 are on the right. Chr7 
and der(7) indicate the chromosome 7, normal or rearranged respectively. The thickest line indicates 
the median value (0.65) roughly delimitating the peripheral/inner nuclear compartment. The double 
red arrows compare the values corresponding to HLXB9 allele located in the normal and in the 
rearranged chromosome 7. B: Statistical significance (P values) of the differences in the RNL data 
obtained for each probe respect to the others. Two tails T-test were applied for all pairs of data and the 
obtained P value is indicated in the corresponding box. NS: statistically not-significant. The 
underlined values correspond to the comparison between the HLXB9 alleles on the normal and the 
rearranged chromosome 7, and indicated by the arrows in the upper chart. 
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Fig. 4. Schematic representation of RNL data shown in figure 3. The location of RP5-1121A15 
probe (containing the HLXB9 gene) in the non-translocated chromosome 7 (chr7) is always localised 
more internally in the nucleus, whereas the same probe on the der(7) is consistently localised in a 





Fig. 5. Genomic properties of the 6q23 and 7q36 region involved in the translocation. 
Chromosomal bands, GC-level of the genomic DNA (isochores) and lamina associated domains 
(LADs) were all assembled in a comprehensive schematic in relation to each other in the 
chromosomes 6 (upper panel) and 7 (lower panel) as previously shown [Jabbari and Bernardi, 2017]. 
Chromosomal bands at a resolution of 850 bands per haploid genome show in red the GC-richest 
regions that correspond to the highest density of the GC-richest isochore family H2 and H3 (data from 
Costantini et al., 2007). The intermediate graph shows the distribution of DNA segments relative to 
the GC level of the isochores (data from Costantini et al., 2006). The upper graph in both panels shows 
the distribution of the LADs along the two chromosomes (data from Kind et al., 2015). The coloured 
areas between GC-level graph and chromosomal bands correlate the DNA sequence and the 
chromosomal bands according to Costantini et al., 2007. The arrows in the LAD graph indicate the 




Additional information on PAC RPCI-5-48H15 
Genome Browser on Human Feb. 2009 (GRCh37/hg19) Assembly 
 
Start sequence 
tttccctcccacattgccctastaraggttctccatgagggctctgcccctgcagtggayttctgctt
ggacattcaggccttttcatacaacctctgaaatttaggkggaggctcccaagcctcaactcttgccc
yctgggaacccacaggcttaacaccatgtggaagccatcatagctkgkggcttgcmcccyctgagcas
cagcctgagacatctgtgggtctcttttagccmcagctggagctggagtttttgggacacagggagca
gtgtcccaaggttgtgcaaggcagtggggccctgggcctggtctgtgaaaccwttcttccctcctaar
actccaagcctgtgatgggaggggctgctgaraaggtctctgaaatgccttctgggaattttccctat
tgtcttggctattaacatttggcttccctttacttatgcaaatttctgtagctggcttgaattcctcc
ccagaaaatgggtttttcctttctaccacatggtcaggctgaaaattttctaaattattatgctgtac
ttcccttttaaatataagttccagggcaggcatggtggctcatacctgwaatcccaacactttgagag
gccaaggccagtggatcacttymggttaggagtttgagcccaacttggccaacatggcgaaaccttgt
ctctactaaaaatacaaaaattatctgggtgtagtgacacacacctatagtcccagctacttgggagg
ctgasgcaggagga 
 
End sequence 
gggtttcaccatgtkggtcmggctggtytckamytcccgacctcaggtgatccacccacttcagcctc
ccaaagkgctgggattacaggcatgagcgaccgtgcccgggctatcatctccattttctagagtacaa
gttcaragagtttgggatccttgttcccmgcaracagtttggccttaragytgggagkgggaccaggt
ctgattgcaraggccacactgttcccaccctgctgccctcaaagctttcaggtacacctagccctgag
tccccatcccatctgtttctttttggggagggaaggattgtaaaggaraccaragattcttagccacc
tgtcccaggcaggaagccctagytgtgactctgcctccccagggtagagaacacagccttggcctcct
cctccaggggtttggcaccaaggctgacttgcctttctcttctcatcacccccatctgctgggggcag
attgcttggtcctgaggtcaatgatttagggagctgggggaagggagtggctgcagaagaaatctccc
aggatggaccttggagaagatgctgttcctctctccaaccaaaaatacacactgccagggtgatttta
gttggtgatggggtgtgtagtctagactcatgacatcagccatctccttcaacaaaatcacagtgggt
gttttctggcttttttttttaactcctagaggaattaatttcacccctttttgttctgtaataaccat
ggtccaaaaccccttc 
 
